tldrdailynews.com logo
Tag

Flu Vaccine

All articles tagged with #flu vaccine

FDA approves first mRNA flu shot for adults 50+, aiming for better strain matching
health12 days ago

FDA approves first mRNA flu shot for adults 50+, aiming for better strain matching

FDA approves Moderna’s mRNA-based flu vaccine, mFlusiva, for adults 50 and older (standard approval for ages 50–64 and accelerated approval for 65+), leveraging faster manufacturing to allow strain updates closer to the season. In a large trial, it was about 27% more effective than standard flu shots in people over 50 but had more mild to moderate side effects; serious events were similar to other vaccines. A post-marketing study is required, and availability may be limited this fall while a CDC recommendation is pending due to a delay in the ACIP meeting. Insurance coverage remains uncertain until guidelines are issued. The vaccine could be a valuable option for an older population at higher risk of severe flu outcomes.

via CNN|
#fda-approval#flu-vaccine#health
FDA approves first mRNA flu vaccine for adults 50+, aiming for better strain matching
health12 days ago

FDA approves first mRNA flu vaccine for adults 50+, aiming for better strain matching

FDA approves Moderna’s mFlusiva, the first mRNA-based flu vaccine, for adults 50+, with standard approval for 50–64 and accelerated approval for 65+, enabling faster production and closer strain matching; in a 40,000+ participant trial it was about 27% more effective than standard vaccines for ages 50+, though with more transient side effects; a post-marketing study is required, rollout may be limited this fall, and insurance coverage remains unclear until ACIP weighs in (scheduled for October).

via CNN|
#fda-approval#flu-vaccine#health
New Flu Shot for 50+ Promises Stronger Protection This Fall
health13 days ago

New Flu Shot for 50+ Promises Stronger Protection This Fall

FDA-approved Moderna’s mFlusiva, an mRNA flu vaccine, for adults 50–64 (full approval) and 65+ (accelerated approval) after trials showed about 27% higher effectiveness than the standard flu shot; the vaccine could be updated quickly to address circulating strains. It’s expected to be available this fall, though insurance coverage remains unclear. Side effects may be stronger than with traditional vaccines but are generally mild. Health experts say to get whichever flu vaccine is available to protect yourself early in the season.

via AOL.com|
#flu-vaccine#health#mflusiva
New Moderna Flu Shot for 50+ Boosts Protection, Speeds Up Vaccine Production
health15 days ago

New Moderna Flu Shot for 50+ Boosts Protection, Speeds Up Vaccine Production

Regulators approved Moderna’s mFlusiva, a new mRNA flu vaccine, for adults 50 to 64 (fully) and 65+ (accelerated) after trials showed about 27% greater effectiveness than standard flu shots; the vaccine, available this fall, uses mRNA technology to allow faster production and potential yearly updates to match circulating strains, though side effects may be stronger than traditional vaccines; if you’re eligible, get whichever flu shot is available to start protection early in the season.

via HuffPost|
#adults-50-to-64#flu-vaccine#health
First mRNA Flu Vaccine Clears FDA Hurdle, Signaling a New Era in Vaccines
health15 days ago

First mRNA Flu Vaccine Clears FDA Hurdle, Signaling a New Era in Vaccines

The FDA has approved Moderna’s mFlusiva as the United States' first mRNA flu vaccine, giving adults 50+ access with full approval for ages 50–64 and accelerated approval for 65+, following a trial that showed it outperformed a standard-dose flu vaccine and suggesting mRNA could speed vaccine updates to evolving flu strains and potentially improve seasonal vaccines.

via ZME Science|
#fda#flu-vaccine#health
First US mRNA flu vaccine signals a new era for vaccines
future-perfect18 days ago

First US mRNA flu vaccine signals a new era for vaccines

FDA approves mFLUSIVA, the United States’ first mRNA influenza vaccine, marking a milestone for the platform after a year of funding reversals; unlike egg-based vaccines, it can be updated in two to three months and deployed closer to flu season, hinting at future breakthroughs across vaccines and therapies, though real-world uptake will depend on access, cost, and regulatory guidance.

via vox.com|
#fda-approval#flu-vaccine#future-perfect
mFlusiva: New mRNA flu shot outperforms traditional vaccines, but uptake may lag
health18 days ago

mFlusiva: New mRNA flu shot outperforms traditional vaccines, but uptake may lag

FDA-approved Moderna’s mFlusiva for adults 50+ after a large study in adults aged 50-64 showed it’s about 26.6% more effective than traditional flu vaccines; approval for 65+ is provisional pending more data. Experts say it could better match circulating strains and save lives, but public concerns about mRNA and misinformation may hinder uptake, particularly on Long Island where flu vaccination rates hover around 48%.

via Newsday|
#fda-approval#flu-vaccine#health
FDA approves Moderna’s mRNA flu shot for adults 50+, signaling a new vaccine era
health20 days ago

FDA approves Moderna’s mRNA flu shot for adults 50+, signaling a new vaccine era

FDA approval grants Moderna’s mRNA influenza shot, mFLUSIVA (mRNA-1010), for adults 50 and up, marking the first mRNA flu vaccine and following a unanimous June advisory panel vote citing strong efficacy and safety in about 44,000 people. The path to approval was politically tense due to anti-vaccine motivations within the Kennedy administration, and questions remain about ACIP recommendations, coverage, and near-term sales expectations, with Moderna aiming for the 2026–27 season.

via Ars Technica|
#acip#fda-approval#flu-vaccine
US approves groundbreaking mRNA flu vaccine for adults 50+
health20 days ago

US approves groundbreaking mRNA flu vaccine for adults 50+

The FDA approved Moderna’s first mRNA-based flu vaccine (mFLUSIVA) for adults 50 and older—the first of its kind—with a study of over 40,000 participants showing about 27% higher effectiveness than standard seasonal flu shots during the 2024–25 season. Moderna expects a fall rollout, with the CDC’s advisory committee expected to weigh in on a formal immunization recommendation after unanimously supporting the vaccine’s benefits for older adults.

via CNN|
#fda#flu-vaccine#health
FDA approves Moderna’s mRNA flu shot, first of its kind
health21 days ago

FDA approves Moderna’s mRNA flu shot, first of its kind

FDA approved Moderna’s mFlusiva, the first mRNA flu vaccine, for adults 50–65 and 65+, with a condition for another trial in the older cohort; in late-stage trials it was roughly 27% more effective than a standard flu shot. The vaccine’s mRNA platform allows faster strain updates (2–3 months vs about 6 months for traditional vaccines), but its rollout faces insurance and policy hurdles since ACIP guidance is blocked, though it could be prescribed without it.

via NBC News|
#acip#fda#flu-vaccine
EU opens antitrust probe into Sanofi’s flu vaccine marketing
business1 month ago

EU opens antitrust probe into Sanofi’s flu vaccine marketing

The European Commission has opened formal antitrust proceedings against Sanofi over its marketing of the flu vaccine Efluelda, accusing the company of a misleading campaign that portrayed CSL Seqirus’ Fluad as inferior and contradicted national vaccination guidance in Germany and France; the probe targets Sanofi’s messaging to healthcare professionals and its dominant market position, nine months after EC raids, with Sanofi saying it will address the concerns. CSL reported Fluad sales of about $901 million last year, while Sanofi does not disclose vaccine sales; Efluelda is sold as Fluzone HD in the US.

via Fierce Pharma|
#antitrust#business#csl-seqirus
Military Leaders Sought Flu Shots Ahead of Training-Base Outbreak
military2 months ago

Military Leaders Sought Flu Shots Ahead of Training-Base Outbreak

Weeks before a flu outbreak swept through an Air Force basic training wing in San Antonio, leaders from the Army, Navy, Marine Corps and Air Force asked Defense Secretary Pete Hegseth for permission to vaccinate recruits after he lifted the flu vaccine requirement in April; approval arrived on June 16, by which time the outbreak was already underway.

via The New York Times|
#basic-training#defense-department#flu-outbreak
Air Force Restores Flu Shot Mandate as Boot-Camp Flu Surge Unfolds
us-military2 months ago

Air Force Restores Flu Shot Mandate as Boot-Camp Flu Surge Unfolds

Amid a growing flu outbreak at Lackland Air Force Base that sickened about 275 recruits and involved a fatal medical event, the Air Force moved to reinstate the mandatory flu vaccine for basic training after Defense Secretary Pete Hegseth reversed the policy in April. Exemption requests slowed the process; the mandate was approved on June 11, but the outbreak was already underway, and officials learned June 18 that shots would be required again for incoming trainees.

via CNN|
#basic-training#defense-department#exemptions
Regulatory drama ends with unanimous FDA advisory vote for Moderna's mRNA flu vaccine
health2 months ago

Regulatory drama ends with unanimous FDA advisory vote for Moderna's mRNA flu vaccine

FDA advisors voted 9-0 to approve Moderna’s mRNA-1010 seasonal flu vaccine (mFlusiva) after a Trump-era official briefly blocked review; Phase 3 data show ~27% higher efficacy than standard flu vaccines in adults 50+, with strong immune responses in older adults and a generally favorable safety profile. A final FDA decision is due by August 5, and CDC/ACIP recommendations would follow for coverage, though ACIP is currently affected by an injunction tied to vaccine-administration policy.

via Ars Technica|
#fda#flu-vaccine#health